心脏性冲击管理的演变和多学科团队式方法的发展:单一中心的十年经验
Leonardo Belfioretti1, Matteo Francioni1, Ilaria Battistoni1
1Intensive Care Unit, Cardiology Department, Azienda Ospedaliero-Universitaria delle Marche, 60126 Ancona, Italy.
Journal of clinical medicine
|April 13, 2024
概括
实施多学科冲击团队显著降低了急性冠状动脉综合征和心脏性冲击 (ACS-CS) 患者的住院死亡率. 这种涉及专业护理的方法,尽管初始死亡率高,但改善了结果.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 干预心脏病学 干预心脏病学
背景情况:
- 随着急性冠状动脉综合征 (ACS) 发生的心脏性休克 (CS) 是一个重大的管理挑战,死亡率持续高.
- 不断发展的治疗策略强调基于多学科的团队护理,以改善患者的治疗结果.
研究的目的:
- 评估多学科团队方法对ACS-CS患者住院死亡率的影响.
- 分析管理策略的趋势及其与随时间推移死亡率的相关性.
主要方法:
- 一项回顾性研究包括了167名在2012年3月至2021年7月期间入院的缺血性CS患者.
- 2019年成立了一个专门的"冲击队",包括重症监护,干预心脏病学,麻醉和心脏手术专家.
- 住院死亡率是主要的结局指标,分析了治疗方式和患者特征的趋势.
主要成果:
- 在研究期间,住院死亡率显著下降,从57%降至29% (OR = 0.90,p = 0.0015).
- 管理中的关键变化包括增加使用Impella导管 (p = 0.0005) 和特定的内类药物,如dobutamine和levosimendan (p = 0.015,p = 0.0001).
- 严重的左心室功能障碍很常见 (66%),心血管血管血管学会和干预 (SCAI) 冲击阶段E与预后不佳有关 (OR 28.50,p = 0.039).
结论:
- 在CS患者中观察到的死亡率降低可能是多因素的,由不断变化的管理策略驱动.
- 多学科"冲击队"的实施以及机械心脏支持和药物治疗的进步在改善生存率方面显得至关重要.
更多相关视频
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.6K
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
11.7K
相关概念视频
01:24Blood Pressure Imbalances and Circulatory Shock
773
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
773
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:27Development of the Heart
929
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
929